




























![]()
Q1: 2026-04-30 Earnings Summary
EPS of $0.36 misses by $0.10
|
Revenue of
$1.42B
(5.05% Y/Y)
beats by $6.95M
Select Medical Holdings Corporation (SEM) Q1 2026 Earnings Call May 1, 2026 9:00 AM EDT
Company Participants
Thomas Mullin - Chief Executive Officer
Michael Malatesta - Executive VP & CFO
Conference Call Participants
Benjamin Hendrix - RBC Capital Markets, Research Division
Ann Hynes - Mizuho Securities USA LLC, Research Division
Joaquin Eduardo Martinez - BofA Securities, Research Division
Presentation
Operator
Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the first quarter 2026 results and the company's business outlook.
Presenting today are the company's Chief Executive Officer, Thomas Mullin; and the company's Executive Vice President and Chief Financial Officer, Michael Malatesta. Also on the conference line is the company's Senior Vice President, Controller and Chief Accounting Officer, Christopher Weigl. Management will give you an overview of the quarter and then open the call for questions.
Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities and other statements that refer to Select Medical's plans, expectations, strategies, intentions and beliefs. These forward-looking statements are based on the information available to management of Select Medical today, and the company assumes no obligation to update these statements as circumstances change.
At this time, I will turn the conference over to Mr. Thomas Mullin. Please go ahead.
Thomas Mullin
Chief Executive Officer
Thank you, operator, and good morning, everyone. Welcome to Select Medical's earnings call for the first quarter of 2026. I'd like to begin today's call with a brief update on our previously announced take-private transaction. On March 2, we announced that Select Medical entered into an agreement to be acquired by a consortium led by our Executive Chairman, Robert Ortenzio, together with Martin Jackson
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。